Teladoc (TDOC) Misses Q2 EPS by 11c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Teladoc Health Reports Second-Quarter 2020 Results
July 29, 2020 4:06 PM EDTYear-over-year Q2 revenue grows 85% to $241.0 million and total visits increase 203% to 2.8 million
Year-over-year six months revenue grows 63% to $421.8 million and total visits increase 144% to 4.8 million
Issues 2020 third-quarter guidance, raises full-year expectations, and provides preliminary 2021 revenue growth outlook
PURCHASE, NY, July 29, 2020 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC),... More
